Microport
MicroPort Scientific Corporation, commonly referred to as MicroPort, is a leading global medical device company headquartered in China. Founded in 1998, the company has established a strong presence in various operational regions, including Asia, Europe, and North America. Specialising in orthopaedics, cardiovascular, and surgical devices, MicroPort is renowned for its innovative products that enhance patient outcomes and streamline surgical procedures. With a commitment to research and development, MicroPort has achieved significant milestones, including the launch of advanced technologies in minimally invasive surgery. The company’s core offerings, such as its cutting-edge stent systems and joint replacement solutions, are distinguished by their quality and efficacy. Recognised for its contributions to the medical field, MicroPort continues to solidify its market position as a trusted provider of medical solutions worldwide.
DitchCarbon Score
How does Microport's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Microport's score of 25 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Microport's reported carbon emissions
In 2023, Microport reported total carbon emissions of approximately 1,665,120 kg CO2e, with Scope 1 emissions at about 89,320 kg CO2e and Scope 2 emissions at approximately 1,575,800 kg CO2e. This marked a significant reduction from 2022, where total emissions were about 1,840,100 kg CO2e. In 2021, the company recorded total emissions of approximately 40,144,000 kg CO2e, with Scope 1 emissions at about 7,160 kg CO2e and Scope 2 emissions at approximately 2,912,000 kg CO2e. The emissions for 2020 were even higher, at about 45,720,000 kg CO2e, with Scope 1 and Scope 2 emissions combined at approximately 2,490,610 kg CO2e. Despite these reductions, Microport has not publicly disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company continues to focus on improving its emissions intensity relative to revenue, which reflects its commitment to sustainability within the medical technology industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 4,610 | 0,000 | 000,000 | 00,000 |
| Scope 2 | 2,486,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Microport is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
